[A clinical study of IGEV regimen in the treatment of relapsed and refractory Hodgkin lymphoma]
Zhonghua Xue Ye Xue Za Zhi
.
2018 Aug 14;39(8):688-690.
doi: 10.3760/cma.j.issn.0253-2727.2018.08.017.
[Article in Chinese]
Authors
Y Tang
,
X T Wang
,
Y Y Li
,
O Bai
,
S J Gao
,
C S Liu
PMID:
30180475
PMCID:
PMC7342832
DOI:
10.3760/cma.j.issn.0253-2727.2018.08.017
No abstract available